This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention CenterBoston, USA

Jeff Johnson
President at Biotech Design, LLC


Jeff Johnson is currently President of Biotech Design LLC, a bioprocess engineering consultancy. Previously he was with Merck & Co., Inc, where he was New Technology Lead and Director, Global Engineering Solutions, responsible for the assessment of new manufacturing technology for Merck's vaccine, biologics, and sterile manufacturing processes. He co-led SUN - Merck's Single Use Technology initiative, and the Process Technology Innovation Community of Practice. Prior roles at Merck include Director of BioProcess Engineering, responsible for business case and concept development for new vaccine and biologics capital projects, Director of Network Management for Therapeutic Protein Commercialization, and the Technology Transfer Team Leader for Gardasil. Prior to Merck, he worked for Genzyme Corporation, Raytheon Engineers, Koch Engineering, and ARCO Chemical Co. He holds a BS in Chemical Engineering from the University of Rochester, a MS in Chemical Engineering from the University of Pennsylvania, and a Certificate in Biotechnology from Tufts University.

Agenda Sessions

  • Chairperson’s Opening Remarks: Manufacturing Strategy